Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
-
New hope for head and neck cancer: which drug works best with radiation?
Disease control Not yet recruitingThis study compares two treatments for people with advanced head and neck cancer who cannot use the standard drug cisplatin. About 454 participants will receive either cetuximab (a targeted antibody) or a chemotherapy combo (carboplatin + paclitaxel) alongside precise radiation t…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New radiation rhythm may outsmart glioblastoma and save memory
Disease control Not yet recruitingThis phase III trial tests a new way to deliver radiation called TMPRT, which gives the total dose in short pulses with breaks in between, for people with a newly diagnosed, aggressive brain cancer (MGMT-unmethylated glioblastoma). About 398 adults will be randomly assigned to ge…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Major trial asks: is radiation necessary for Low-Risk breast lesions?
Knowledge-focused Not yet recruitingThis study looks at women with a very early form of breast cancer called DCIS. It uses a special test to find those at low risk of the cancer coming back. The goal is to see if these low-risk women can skip radiation therapy after their lump-removal surgery without a meaningful i…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC